|
Market Closed -
Nasdaq Stockholm
09:30:00 04/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1,555.50 SEK | -0.96% |
|
-0.22% | -8.69% |
| 05:39am | AstraZeneca wins US nod for Etcamah breast cancer combo | AN |
| 06/09 | AstraZeneca's Etcamah Combination Authorized for Advanced Breast Cancer Treatment in US | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,02400Cr | |||||
| 66TCr | - | - | - | ||
| 45TCr | |||||
| 35TCr | |||||
| 30TCr |
Select your edition
All financial news and data tailored to specific country editions
